-
Je něco špatně v tomto záznamu ?
Hyperuricemia and gout due to deficiency of hypoxanthine-guanine phosphoribosyltransferase in female carriers: New insight to differential diagnosis
E. Kostalova, K. Pavelka, H. Vlaskova, D. Musalkova, B. Stiburkova,
Jazyk angličtina Země Nizozemsko
Typ dokumentu kazuistiky, časopisecké články, práce podpořená grantem
- MeSH
- diferenciální diagnóza MeSH
- dítě MeSH
- dna (nemoc) etiologie genetika MeSH
- dospělí MeSH
- heterozygot MeSH
- hyperurikemie diagnóza etiologie MeSH
- hypoxanthin moč MeSH
- hypoxanthinfosforibosyltransferasa nedostatek genetika MeSH
- lidé MeSH
- mutace * MeSH
- novorozenec MeSH
- rodokmen MeSH
- xanthin moč MeSH
- Check Tag
- dítě MeSH
- dospělí MeSH
- lidé MeSH
- mužské pohlaví MeSH
- novorozenec MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- kazuistiky MeSH
- práce podpořená grantem MeSH
BACKGROUND: X-linked hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency in an inherited disorder of purine metabolism is usually associated with the clinical manifestations of hyperuricemia. A variable spectrum of neurological involvement occurs predominantly in males. Females are usually asymptomatic. Carrier status cannot be confirmed by biochemical and enzymatic methods reliably. METHODS: We studied clinical, biochemical and molecular genetic characteristics of Czech families with hyperuricemia and HPRT deficiency. We analyzed age at diagnosis, clinical symptoms, uricemia, urinary hypoxanthine and xanthine, HPRT activity in erythrocytes, mutation in the HPRT1 gene, X-inactivation, and major urate transporters. RESULTS: A mutation in the HPRT1 gene in family A was confirmed in one boy and four females. Three females with hyperuricemia had normal excretion of purine. One female was normouricemic. An 8-month-old boy with neurological symptoms showed hyperuricemia, increased excretion of urinary hypoxanthine and xanthine and a very low HPRT activity in erythrocytes. We have found three other unrelated female carriers with hyperuricemia and normal excretion of hypoxanthine and xanthine among other families with HPRT deficiency. CONCLUSIONS: HPRT deficiency needs to be considered in females with hyperuricemia with normal excretion of purine metabolites. Familiar hyperuricemia and/or nonfamiliar gout should always be further investigated, especially in children.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16000483
- 003
- CZ-PrNML
- 005
- 20160122123212.0
- 007
- ta
- 008
- 160108s2015 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.cca.2014.11.026 $2 doi
- 035 __
- $a (PubMed)25476133
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Kostalova, Eva $u Institute of Inherited Metabolic Disorders, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic.
- 245 10
- $a Hyperuricemia and gout due to deficiency of hypoxanthine-guanine phosphoribosyltransferase in female carriers: New insight to differential diagnosis / $c E. Kostalova, K. Pavelka, H. Vlaskova, D. Musalkova, B. Stiburkova,
- 520 9_
- $a BACKGROUND: X-linked hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency in an inherited disorder of purine metabolism is usually associated with the clinical manifestations of hyperuricemia. A variable spectrum of neurological involvement occurs predominantly in males. Females are usually asymptomatic. Carrier status cannot be confirmed by biochemical and enzymatic methods reliably. METHODS: We studied clinical, biochemical and molecular genetic characteristics of Czech families with hyperuricemia and HPRT deficiency. We analyzed age at diagnosis, clinical symptoms, uricemia, urinary hypoxanthine and xanthine, HPRT activity in erythrocytes, mutation in the HPRT1 gene, X-inactivation, and major urate transporters. RESULTS: A mutation in the HPRT1 gene in family A was confirmed in one boy and four females. Three females with hyperuricemia had normal excretion of purine. One female was normouricemic. An 8-month-old boy with neurological symptoms showed hyperuricemia, increased excretion of urinary hypoxanthine and xanthine and a very low HPRT activity in erythrocytes. We have found three other unrelated female carriers with hyperuricemia and normal excretion of hypoxanthine and xanthine among other families with HPRT deficiency. CONCLUSIONS: HPRT deficiency needs to be considered in females with hyperuricemia with normal excretion of purine metabolites. Familiar hyperuricemia and/or nonfamiliar gout should always be further investigated, especially in children.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a diferenciální diagnóza $7 D003937
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a dna (nemoc) $x etiologie $x genetika $7 D006073
- 650 _2
- $a heterozygot $7 D006579
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hyperurikemie $x diagnóza $x etiologie $7 D033461
- 650 _2
- $a hypoxanthin $x moč $7 D019271
- 650 _2
- $a hypoxanthinfosforibosyltransferasa $x nedostatek $x genetika $7 D007041
- 650 _2
- $a novorozenec $7 D007231
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 12
- $a mutace $7 D009154
- 650 _2
- $a rodokmen $7 D010375
- 650 _2
- $a xanthin $x moč $7 D019820
- 655 _2
- $a kazuistiky $7 D002363
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Pavelka, Karel $u Institute of Rheumatology, Prague, Czech Republic.
- 700 1_
- $a Vlaskova, Hana $u Institute of Inherited Metabolic Disorders, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic.
- 700 1_
- $a Musalkova, Dita
- 700 1_
- $a Stiburkova, Blanka $u Institute of Inherited Metabolic Disorders, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Prague, Czech Republic; Institute of Rheumatology, Prague, Czech Republic. Electronic address: stiburkova@revma.cz.
- 773 0_
- $w MED00009464 $t Clinica chimica acta; international journal of clinical chemistry $x 1873-3492 $g Roč. 440, č. - (2015), s. 214-7
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25476133 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160108 $b ABA008
- 991 __
- $a 20160122123333 $b ABA008
- 999 __
- $a ok $b bmc $g 1102764 $s 924689
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 440 $c - $d 214-7 $e 20141201 $i 1873-3492 $m Clinica chimica acta $n Clin Chim Acta $x MED00009464
- LZP __
- $a Pubmed-20160108